Arcturus Therapeutics Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Arcturus Therapeutics Holdings generated cash of -$18,099,000, which is less than the previous year. Cash used in financing activities reached the amount of -$24,087,000 last year. Net change in cash is therefore -$45,087,000.
Cash Flow
| 2014 | -28.32M | 8.40M | 0 |
|---|---|---|---|
| 2015 | -18.14M | -33.84M | 66.47M |
| 2016 | -19.24M | 4.88M | 6K |
| 2017 | -460K | 10.35M | 6.99M |
| 2018 | -20.76M | 22.13M | 10.20M |
| 2019 | -6.44M | -818K | 41.90M |
| 2020 | -42.86M | -1.74M | 436.14M |
| 2021 | -135.04M | -3.40M | 48.01M |
| 2022 | 31.99M | -7.72M | -2.85M |
| 2023 | -18.09M | -2.90M | -24.08M |
ARCT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 393.97M | 372.56M | 463.00M | 71.46M | 36.81M | 25.23M | 8.34M | 16.65M | 2.17M | 22.09M |
Operating activities | ||||||||||
Net income | -29.72M | 9.34M | -203.67M | -72.14M | -25.99M | -21.78M | -10.90M | -24.60M | -19.44M | -32.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.95M | 1.52M | 1.19M | 882K | 684K | 582K | 410K | 61K | 51K | 31K |
Stock-based compensation expense | 34.64M | 30.61M | 28.91M | 6.76M | 1.98M | 0 | 2.17M | 2.5M | 2.36M | 4.08M |
| Deferred income tax benefit | 34.64M | 30.61M | 28.91M | 6.76M | 1.98M | 0 | 2.17M | 2.5M | 2.36M | 4.08M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -29.3M | 603K | -1.24M | 54K | 2.30M | -4.00M | 3.15M | 0 | -1.07M | 0 |
Inventories | 0 | 0 | 450K | 9.30M | 1.55M | 2.10M | -306K | 0 | 0 | 0 |
Accounts payable | -2.23M | -3.11M | -769K | 4.81M | 3.15M | 578K | -1.53M | 471K | -248K | 258K |
Cash generated by operating activities | -18.09M | 31.99M | -135.04M | -42.86M | -6.44M | -20.76M | -460K | -19.24M | -18.14M | -28.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -6.59M | 0 | -17.37M | -33.5M | 0 |
Investments In Property Plant And Equipment | -2.90M | -7.72M | -3.40M | -1.74M | -818K | -1.47M | -251K | -74K | -181K | -79K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 29K | -20.02M | 0 | 0 |
Cash generated by investing activities | -2.90M | -7.72M | -3.40M | -1.74M | -818K | 22.13M | 10.35M | 4.88M | -33.84M | 8.40M |
Financing activities | ||||||||||
Common Stock Issued | 609K | 411K | 515K | 423.81M | 21.27M | 0 | 477K | 0 | 66.45M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -27.36M | -5M | -46.59M | 0 | 4.94M | 0 | 5.65M | 0 | 1.88M | 0 |
Cash used in financing activities | -24.08M | -2.85M | 48.01M | 436.14M | 41.90M | 10.20M | 6.99M | 6K | 66.47M | 0 |
Net Change In Cash | -45.08M | 21.40M | -90.43M | 391.54M | 34.64M | 11.57M | 16.89M | -14.35M | 14.48M | -19.91M |
Cash at end of period | 348.89M | 393.97M | 372.56M | 463.00M | 71.46M | 36.81M | 25.23M | 2.30M | 16.65M | 2.17M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |